XML 22 R11.htm IDEA: XBRL DOCUMENT
v3.22.2

Intangibles, Net and Goodwill | 6 Months Ended
--- | ---
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract] |
Intangibles, Net and Goodwill | Intangibles, Net and Goodwill Intangibles, Net Finite-lived Intangible Assets As of June 30, 2022, the Company's finite-lived intangible assets consisted of acquired ARIKAYCE R&D and the milestones paid to PARI Pharma GmbH (PARI) for the license to use PARI's Lamira® Nebulizer System (Lamira) for the delivery of ARIKAYCE to patients as a result of the FDA and EC approvals of ARIKAYCE in September 2018 and October 2020, respectively. The Company began amortizing its acquired ARIKAYCE R&D and PARI milestones intangible assets in October 2018, over ARIKAYCE's initial regulatory exclusivity period of 12 years. Amortization of these assets during each of the next five years is estimated to be approximately $5.1 million per year. Indefinite-lived Intangible Assets As of June 30, 2022, the Company's indefinite-lived intangible assets consisted of acquired in process research and development (IPR&D) from the Business Acquisition (Note 13). Indefinite-lived intangible assets are not amortized. A rollforward of the Company's intangible assets for the six months ended June 30, 2022 and June 30, 2021 is as follows (in thousands):
Intangible Asset | December 31, 2021 |  | Additions |  | Amortization |  | June 30, 2022
Acquired ARIKAYCE R&D | $ | 42,439 |  |  | $ | — |  |  | $ | (2,425) |  |  | $ | 40,014 |
Acquired IPR&D | 29,600 |  |  | — |  |  | — |  |  | 29,600 |
PARI milestones | 1,770 |  |  | — |  |  | (101) |  |  | 1,669 |
| $ | 73,809 |  |  | $ | — |  |  | $ | (2,526) |  |  | $ | 71,283 |
Intangible Asset | December 31, 2020 |  | Additions |  | Amortization |  | June 30, 2021
Acquired ARIKAYCE R&D | $ | 47,289 |  |  | $ | — |  |  | $ | (2,425) |  |  | $ | 44,864 |
PARI milestones | 1,972 |  |  | — |  |  | (101) |  |  | 1,871 |
| $ | 49,261 |  |  | $ | — |  |  | $ | (2,526) |  |  | $ | 46,735 |
Goodwill The Company's goodwill balance of $136.1 million as of June 30, 2022, resulted from the Business Acquisition (Note 13).

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -URI https://asc.fasb.org/subtopic&trid=2144471 + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration